Skip to main content
Clinical Trials/JPRN-UMIN000042743
JPRN-UMIN000042743
Completed
未知

Perioperative nutrition support and exercise for preventing skeletal muscle loss in patients with esophageal cancer undergoing esophagectomy; a prospective study. - Perioperative nutrition support and exercise for preventing skeletal muscle loss in patients with esophageal cancer undergoing esophagectomy; a prospective study.

Kyoto University Hospital0 sites35 target enrollmentDecember 14, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kyoto University Hospital
Enrollment
35
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 14, 2020
End Date
March 31, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.patients who had past history of treatment for esophageal cancer 2\.patients who were treated for other cancer within 1 year before registration. 3\. Patients with active double cancer who are expected to require surgery, chemotherapy, or radiation therapy within 3 months of the date of consent. 4\. Patients who are judged to be difficult to undergo intervention due to heart disease, osteoarthritis, neurological disease, etc. 5\. Patients with psychosis or psychiatric symptoms who are judged to have difficulty in participating in this trial 6\. Patients who have difficulty with adequate food, oral intake of oral preparations, and digestion and absorption (patients with chronic nausea, vomiting or gastrointestinal obstruction, etc.) 7\. Patients who had myocardial infarction or unstable angina within 6 months of study enrollment 8\. Patients with uncontrolled hypertension and persistent arrhythmias despite appropriate treatment (although patients with stable chronic atrial fibrillation receiving stable anticoagulant therapy are acceptable) (Patients who have pacemaker are excluded) 9\. Diabetic patients who are or will be taking insulin. uncontrolled diabetics despite proper treatment. 10\. Patients with heart failure, respiratory failure, liver failure 11\. Patients who are judged to be inappropriate in intervention for reasons other than the above

Outcomes

Primary Outcomes

Not specified

Similar Trials